FDA-Approved Patient Isolation Solution Enables Hospitals to Quickly Set Up Emergency Isolation Rooms for COVID-19 Patients

A revolutionary solution for patient isolation that enables hospitals to quickly set up emergency isolation rooms has obtained approval from the US Food and Drug Administration (FDA) and could help battle the COVID-19 pandemic.

JUD care (Shenzhen, China) has developed a portable negative pressure isolation room specially designed to quickly isolate patients while ensure public safety and a great user experience during a large-scale airborne infectious disease outbreak, such as COVID-19. The portable ward named sROOM erects a 6+ square meter single-person negative pressure isolation room in just 10 minutes, making it extremely useful for health emergencies, especially ones involving infectious and respiratory diseases such as COVID-19.


Its fresh air high-efficiency filtration system supplies air with multiple filtration functions and provides abundant fresh air for the room. The exhaust outlet with HEPA filter captures 99.99% pathogens, thus minimizing pathogen transmission. The sROOM maintains proper pressure difference to prevent contaminated air leakage. Proper airflow organization helps reduce the concentration of infectious particles inside the room and ensure the safety of staff. Its auto-open door system helps avoid contact with the door when entering or exiting the isolation room, thus reducing the risk of transmission of pathogens. Emergency backup power supply helps maintain smooth operation in the event of a power failure.

Moreover, it is highly flexible and easy to deploy, with a reusable canopy that can be disinfected, folded, and stored after use. With its ability to ensure instant patient isolation and effective infection control, the sROOM is helping boost the effectiveness of medical and healthcare institutions during the COVID-19 pandemic. With its functional and highly-reliable features, the sROOM is an advantageous one-time investment that can deliver continuous value across wide-ranging scenarios.

"As the world continues to battle the COVID-19 pandemic, JUD care firmly believes that our innovative patient isolation solution sROOM can serve as an effective tool in the fight," said He Wei, COO of JUD care. "Driven by our mission to 'Empower Healthcare with Technology and Commerce', we are committed to delivering effective, reliable, and high-quality solutions. Obtaining FDA approval is an important first step to help American healthcare providers and institutions contain the virus and ensure the health of its people across the country."

Related Links:
JUD care